» Articles » PMID: 38478734

CD40 Expression by B Cells Is Required for Optimal Immunity to Murine Pneumocystis Infection

Overview
Journal J Infect Dis
Date 2024 Mar 13
PMID 38478734
Authors
Affiliations
Soon will be listed here.
Abstract

CD40-CD40 ligand interactions are critical for controlling Pneumocystis infection. However, which CD40-expressing cell populations are important for this interaction have not been well defined. We used a cohousing mouse model of Pneumocystis infection, combined with flow cytometry and quantitative polymerase chain reaction, to examine the ability of different populations of cells from C57BL/6 mice to reconstitute immunity in CD40 knockout mice. Unfractionated splenocytes, as well as purified B cells, were able to control Pneumocystis infection, while B cell-depleted splenocytes and unstimulated bone marrow-derived dendritic cells were unable to control infection in CD40 knockout mice. Pneumocystis antigen-pulsed bone marrow-derived dendritic cells showed early but limited control of infection. Additional findings were consistent with recent studies that suggested a role for antigen presentation by B cells; specifically, by using cells from immunized animals, B cells were able to present Pneumocystis antigens to induce proliferation of T cells. Thus, CD40 expression by B cells appears necessary for robust immunity to Pneumocystis.

Citing Articles

The importance of Fcγ and C-type lectin receptors in host immune responses during pneumonia.

Kottom T, Carmona E, Schaefbauer K, Stelzig K, Pellegrino M, Bindzus M Infect Immun. 2025; 93(2):e0027624.

PMID: 39745390 PMC: 11834440. DOI: 10.1128/iai.00276-24.

References
1.
Helft J, Bottcher J, Chakravarty P, Zelenay S, Huotari J, Schraml B . GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells. Immunity. 2015; 42(6):1197-211. DOI: 10.1016/j.immuni.2015.05.018. View

2.
Roux A, Canet E, Valade S, Gangneux-Robert F, Hamane S, Lafabrie A . Pneumocystis jirovecii pneumonia in patients with or without AIDS, France. Emerg Infect Dis. 2014; 20(9):1490-7. PMC: 4178412. DOI: 10.3201/eid2009.131668. View

3.
Lund F, Schuer K, Hollifield M, Randall T, Garvy B . Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody. J Immunol. 2003; 171(3):1423-30. DOI: 10.4049/jimmunol.171.3.1423. View

4.
Vestereng V, Kovacs J . Recombinant CD40 ligand administration does not decrease intensity of Pneumocystis carinii infection in scid mice. J Eukaryot Microbiol. 2002; Suppl:153S-154S. DOI: 10.1111/j.1550-7408.2001.tb00496.x. View

5.
Laman J, Claassen E, Noelle R . Functions of CD40 and Its Ligand, gp39 (CD40L). Crit Rev Immunol. 2018; 37(2-6):371-420. DOI: 10.1615/CritRevImmunol.v37.i2-6.100. View